Clinical Trial Update: Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and Safety [Phase 2]

View source ↗

Summary

Phase II prospective cohort study evaluating intravesical recombinant human adenovirus type 5 injection for high-risk non-muscle invasive bladder cancer. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Recombinant human adenovirus type 5 (Adenovirus type 5 vector)

Snippet

Sponsor: RenJi Hospital | Conditions: Bladder (Urothelial, Transitional Cell) Cancer | Phase 2 | Status: NOT_YET_RECRUITING